Glenmark Pharma shares surge after its U.S arm, AbbVie ink pact for investigational cancer drug
Glenmark Pharmaceuticals shares surged 10% to ₹2,095.65 on Friday, July 11, 2025. File | Photo Credit: The Hindu The share prices of Glenmark Pharmaceuticals surged 10% to ₹2,095.65 each, hitting the upper circuit in the process, as soon as markets opened on Friday (June 11, 2025) in the backdrop of an exclusive licensing agreement for […]
Continue Reading
